(2) Secondary nephrosis. In this group of conditions a known primary disorder precedes or coexists with the nephrotic syndrome. Causes may be summarized as follows.
(a) Collagen disease: e.g. anaphylactoid purpura, disseminated lupus erythematosus, polyarteritis nodosa.
(b) Quartan malaria: as described from Nigeria (Gilles and Hendrickse, 1963) .
(c) Post-nephritic state: a rare form following acute haemorrhagic glomerulonephritis.
(d) Heavy metal poisoning: due to lead or mercury.
(e) Renal vein thrombosis.
(f) Diverse rare causes: amyloidosis, diabetic glomerulosclerosis, neoplastic infiltration, snake bite, and many others.
* In the 'Personal Practice' series of articles an author is invited to set out his personal views on the handling of some current paediatric problem.
(3) Idiopathic nephrosis. This may be regarded either as a primary disease, or as a secondary disorder, with the primary cause or causes still unknown. It is the common form of nephrosis in childhood, but the less common in adult patients. Unless otherwise specified, the present discussion concerns idiopathic nephrosis.
Assessment of the Case Full history and examination helps to exclude many secondary forms of the disease. Blood pressure is recorded employing as broad a cuff as practicable, and the width of the cuff used is recorded as of importance in comparative estimations. A careful search for concomitant infection is made, particularly to exclude pneumococcal peritonitis or low grade cellulitis. In a patient previously treated elsewhere, evidence of steroid therapy such as Cushingoid obesity, hirsutism, or striae is sought, and osteoporosis is then assessed radiologically. Oliguria is the rule in the oedematous phase, with marked hyposaluria (sodium excretion may be less than 1 mEq daily). Urine osmolality and specific gravity should be within normal limits. Haematuria, when present, consists of intact erythrocytes rather than the smoky quality produced by lysis in the urine of acute haemorrhagic nephritis (Heymann et al., 1958) . McGeachie and Kennedy (1963) or Stansfeld and Webb (1953) . The latter test is simpler and is recommended. These simple quantitations may be complicated by expression in terms of unit time and/or surface area as desired. Initial haematuria carries a bad prognosis, and in a recent series the mortality after 5-10 years was 17% and continuing illness 29% when there was initial haematuria, compared with 7% and 18%, respectively, when there was not (Arneil and Lam, 1966 A further sophistication is the application of immunofluorescent techniques. The presence or absence of 'bumps' of immunoglobulin is established with specific antisera, whose delightful shimmer on microscopy beckons like will-o'-thewisp, and deludes the unwary employer of insufficiently specific agents just as successfully. The work of Drummond et al. (1966) in this respect is worthy of study.
Study of immune protein levels in serum. Investigation of various fractions such as complement and P3 I c-globulin are now well established, but confined to a few centres. P3I c-globulin (a component of complement) is low in level in the plasma when complement is being used, and indicates immunological activity (West, Northway, and Davis, 1964; Gotoffet al., 1965 Dietetic. In the oedematous phase sodium intake is restricted to 0 5-2 g. daily, with a fluid intake of 0 *5-1 litre. Such restriction rarely provokes diuresis, since the urinary sodium excretion may be as low as 1 mEq/day, but it does help to slow the rate of oedema formation. A generous intake of protein is indicated to help minimize the katabolic loss (unless the level of blood urea be raised). Calorie restriction, with a high-protein content in the diet, accompanies intensive steroid therapy in an effort to reduce the development of Cushingoid obesity, moon face, and permanent cutaneous striae. A high-protein diet is continued as long as proteinuria with or without oedema persists, and until the onset of renal failure.
Dietetic treatment of chronic renal failure is beset with problems of personality. There was much to be said for allowing the patient free choice and little restriction when therapeutic nihilism was the rule. It behoves one to remember that to the child (who is about to die) food is a great comfort, and such essentials as mince, bread, and sausages probably justify their protein content on humanitarian grounds. All forms of dietetic restriction-alkaline ash diet, rice diet, Giovanetti diet-are but palliative, and may be an unwarranted imposition unless some positive action such as renal transplant is being considered in the future. (Arneil and Lam, 1966) . These results should be interpreted against the results before steroid treatment, when 48% of children recovered, 20% died of infection within 2 years, and 18% died of renal failure within 10 years (Arneil, 1961) . When initial success has been achieved, the risk of giving prolonged intermittent therapy to the 40% of patients who would not relapse without it, must be balanced against the theoretical risk of increasing liability to one relapse by not giving intermittent therapy following the first response to steroid therapy. It is to be hoped that sophisticated techniques such as differential protein clearances, renal biopsy, immunoglobulin (Soothill, 1962) , [-I c-globulin estimations (Gotoff et al., 1965), or immunofluorescent techniques may prove helpful here. If they could indicate which patients were unlikely to relapse, one could avoid intermittent steroid prophylaxis for children who do not require it, and so avoid the Scylla of long-term unnecessary steroids for 40%, and the Charybdis of delay in the start of long-term steroid treatment for the 53% who require it. It is our practice to give one intensive course, to stop, and, if relapse occurs, to give a second intensive course followed by intermittent treatment for a minimum of six months (Table) .
The most vexatious problem arising from steroids relates not to the 40% who respond and recover, but to the 53% who, having responded in whole or in part, then relapse. A wide range exists, from the child who relapses once or twice in the first year after steroid treatment is begun, but not subsequently, to the child who relapses frequently with complete or incomplete clearance of proteinuria between successive episodes for five or more years. This group with recurrent relapses amounts to some 40 % of all children with primary nephrosis. Some cases will have presented with initial haematuria, will have shown membranous and/or proliferative changes on light microscopy, and will have nonselective proteinuria, and it is amongst this group that the problems of prolonged steroid administration are most clamant.
Complications. These are similar to those seen in the natural disease of hypercorticism. The most common effect, Cushingoid obesity, may be reduced in part by the use of a high-protein and low-carbohydrate diet. Centripetal obesity, with buffalo hump and 'moon' or 'tomato' face, contributes to the stretching and striae of skin over certain areas such as the thighs, abdomen, and on occasions the pubescent mammae. The combination of obesity and oedema with underlying ascites may produce enough tension to cause rupture of striae with subcutaneous oedema leaking out and soaking the skin, a situation vulnerable to infection.
The second problem is that of osteoporosis. We record an osteoporotic index (relation of bicortical diameter to transverse diameter of three bones) initially, and every 3-6 months on steroid thereafter, depending on the intensity of steroid treatment. This gives some indication of the progression or otherwise of osteoporosis. Between intensive steroid courses or on intermittent therapy we encourage a high calcium (milk) intake and give supplements of vitamin D.
The third problem is that of stunting of growth. In any patient this is difficult to assess because of the variation in individual growth pattern, and the tendency to stunting in all chronic renal disease. It is to the latter group that the most steroid is likely to be given for the longest period.
It is because of this danger of growth retardation that various forms of intermittent therapy have been devised. Several theories have been advanced to justify the use of such intermittent therapy. It remains in doubt whether growth suppression is due to steroids competing with or suppressing production of pituitary growth hormone, or to the suppression of so-far unidentified growth-promoting substances in the adrenals.
It has been known for some time that a compensatory growth spurt often occurs after stopping a not too prolonged course of steroids (Blodgett et al., 1956) ; hence the observation of Friedman and Strang (1966) , that oral steroids may cause more short-term growth retardation than ACTH intramuscularly, is less worrying.
Our own cases have recently been analysed, and indicate that intensive steroid therapy for up to 6 months has had no effect on height 5-12 years later. Dwarfism was found in those who had chronic renal disease of long duration and who had had many courses of steroid in high dosage, continuous low dosage, or intermittent dosage. Even in this group only some are seriously dwarfed, and a proportion of this stunting may be due to the renal disease, rather than to steroids. Cytostatic (immunosuppressant) therapy. Several recent publications concem the use of drugs formerly called 'immunosuppressants', but not now thought to be so (White, Cameron, and Trounce, 1966; Shearn, 1965; Grupe and Heymann, 1966) . The place for these drugs is obviously not in treating the 50% who recover within one year of onset on intensive steroid therapy alone, but (if anywhere) in the steroid-resistant, in the frequent relapser, and perhaps in those patients intolerant of high doses of steroid.
The theoretical reasons for the use of such cytotoxic agents as cyclophosphamide and azothioprine are tenuous, and there is at present no convincing trial of their efficiency. The best data are those of Michael et al. (1967) Table. obtained, treatment should probably then be discontinued. Throughout the period the white blood count and platelet count must be monitored several times weekly. Severe leucopenia and/or thrombocytopenia is an indication to discontinue azothioprine therapy and not to restart, since subsequent sensitivity is common. Haemodialysis and renal transplant. In handling the hypertensive and chronic nephrotic in progressive renal failure, one must take stock of the probability of effective renal transplantation becoming available in the near future. Most paediatricians will feel that the physical, emotional, and economic complications of chronic haemodialysis do not justify the use of this technique in young children, unless leading up to renal transplant. Summary Fig. 2 summarizes the views set out in this article.
